Log In
BCIQ
Print this Print this
 

NYK1341

  Manage Alerts
Collapse Summary General Information
Company Nyken B.V.
DescriptionHeat shock factor 1 activator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal damage
Indication DetailsTreat acute kidney injury (AKI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today